Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
Accenture
Boehringer Ingelheim
QuintilesIMS
Baxter
Covington
Moodys
AstraZeneca
McKesson

Generated: May 20, 2018

DrugPatentWatch Database Preview

CYTOXAN (LYOPHILIZED) Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

When do Cytoxan (lyophilized) patents expire, and when can generic versions of Cytoxan (lyophilized) launch?

Cytoxan (lyophilized) is a drug marketed by Baxter Hlthcare and is included in one NDA.

The generic ingredient in CYTOXAN (LYOPHILIZED) is cyclophosphamide. There are nineteen drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the cyclophosphamide profile page.
Summary for CYTOXAN (LYOPHILIZED)
Drug patent expirations by year for CYTOXAN (LYOPHILIZED)
Pharmacology for CYTOXAN (LYOPHILIZED)
Drug ClassAlkylating Drug
Mechanism of ActionAlkylating Activity
Medical Subject Heading (MeSH) Categories for CYTOXAN (LYOPHILIZED)

US Patents and Regulatory Information for CYTOXAN (LYOPHILIZED)

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Baxter Hlthcare CYTOXAN (LYOPHILIZED) cyclophosphamide INJECTABLE;INJECTION 012142-004 Aug 30, 1982 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Baxter Hlthcare CYTOXAN (LYOPHILIZED) cyclophosphamide INJECTABLE;INJECTION 012142-009 Dec 10, 1985 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Baxter Hlthcare CYTOXAN (LYOPHILIZED) cyclophosphamide INJECTABLE;INJECTION 012142-010 Sep 24, 1985 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Baxter Hlthcare CYTOXAN (LYOPHILIZED) cyclophosphamide INJECTABLE;INJECTION 012142-005 Aug 30, 1982 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

Expired US Patents for CYTOXAN (LYOPHILIZED)

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Baxter Hlthcare CYTOXAN (LYOPHILIZED) cyclophosphamide INJECTABLE;INJECTION 012142-008 Jan 4, 1984 ➤ Sign Up ➤ Sign Up
Baxter Hlthcare CYTOXAN (LYOPHILIZED) cyclophosphamide INJECTABLE;INJECTION 012142-010 Sep 24, 1985 ➤ Sign Up ➤ Sign Up
Baxter Hlthcare CYTOXAN (LYOPHILIZED) cyclophosphamide INJECTABLE;INJECTION 012142-009 Dec 10, 1985 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Dow
Healthtrust
Queensland Health
Farmers Insurance
Mallinckrodt
Covington
Express Scripts
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.